Lotzová, E

Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy. [electronic resource] - Leukemia & lymphoma May 1992 - 15-28 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review

1042-8194

10.3109/10428199209053598 doi


Bone Marrow--immunology
Cytotoxicity, Immunologic--drug effects
Humans
Interleukin-2--pharmacology
Killer Cells, Lymphokine-Activated--drug effects
Leukemia--immunology
Major Histocompatibility Complex
T-Lymphocytes--drug effects